EDITOR–Neuberger and Price admit that there is a significant morbidity and an up to 1% mortality among living liver donors.1 They argue that a combination of the potential benefits to the recipient, the right of donors to make an altruistic decision to help someone else, an acceptable “societal ceiling” concerning mortality and morbidity, and an acceptable risk-benefit ratio, are sufficient for living liver …